201 related articles for article (PubMed ID: 19487228)
1. The complexity of managing systemic sclerosis: screening and diagnosis.
Matucci-Cerinic M; Steen V; Nash P; Hachulla E
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii8-13. PubMed ID: 19487228
[TBL] [Abstract][Full Text] [Related]
2. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
[TBL] [Abstract][Full Text] [Related]
3. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
[TBL] [Abstract][Full Text] [Related]
4. Nailfold capillaroscopy in primary biliary cirrhosis: a useful tool for the early diagnosis of scleroderma.
Tovoli F; Granito A; Giampaolo L; Frisoni M; Volta U; Fusconi M; Masi C; Lenzi M
J Gastrointestin Liver Dis; 2014 Mar; 23(1):39-43. PubMed ID: 24689095
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM; Stevens WM; Sahhar J; Celermajer D
Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
Koenig M; Dieudé M; Senécal JL
Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
8. Capillaroscopy.
Cutolo M; Pizzorni C; Secchi ME; Sulli A
Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
[TBL] [Abstract][Full Text] [Related]
9. Classification of systemic sclerosis. Visions and reality.
Wollheim FA
Rheumatology (Oxford); 2005 Oct; 44(10):1212-6. PubMed ID: 15870151
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
Wells AU; Steen V; Valentini G
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
[TBL] [Abstract][Full Text] [Related]
11. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
Ng K; Gow P
N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
[TBL] [Abstract][Full Text] [Related]
12. Predictive markers for development of severe organ involvement in patients with systemic sclerosis.
Ysebrant de Lendonck L; Ocmant A; Roufosse F; Cogan E
Ann N Y Acad Sci; 2005 Jun; 1051():455-64. PubMed ID: 16126987
[TBL] [Abstract][Full Text] [Related]
13. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
Sebastiani M; Manfredi A; Colaci M; D'amico R; Malagoli V; Giuggioli D; Ferri C
Arthritis Rheum; 2009 May; 61(5):688-94. PubMed ID: 19405007
[TBL] [Abstract][Full Text] [Related]
14. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
[TBL] [Abstract][Full Text] [Related]
15. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
Distler O; Behrens F; Pittrow D; Huscher D; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Furst DE;
Arthritis Rheum; 2008 Jun; 59(6):867-75. PubMed ID: 18512721
[TBL] [Abstract][Full Text] [Related]
16. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
Boueiz A; Mathai SC; Hummers LK; Hassoun PM
Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
[TBL] [Abstract][Full Text] [Related]
17. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?
Riccieri V; Germano V; Alessandri C; Vasile M; Ceccarelli F; Sciarra I; Di Franco M; Spadaro A; Valesini G
Clin Exp Rheumatol; 2008; 26(6):992-7. PubMed ID: 19210861
[TBL] [Abstract][Full Text] [Related]
18. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE
Ann Rheum Dis; 2009 Sep; 68(9):1377-80. PubMed ID: 19674983
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
Ulanet DB; Wigley FM; Gelber AC; Rosen A
Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
